230 related articles for article (PubMed ID: 34721775)
1. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors.
Liu LJ; Liao JM; Zhu F
World J Gastrointest Oncol; 2021 Oct; 13(10):1425-1439. PubMed ID: 34721775
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated NF-κB signal promotes the hub gene PCLAF expression to facilitate nasopharyngeal carcinoma proliferation and metastasis.
Ma F; Zhi C; Wang M; Li T; Khan SA; Ma Z; Jing Z; Bo C; Zhou Q; Xia S; Huang S; Huang S; Zhang Z; Jia H; Cui X; Yao M; Ji T
Biomed Pharmacother; 2020 May; 125():109905. PubMed ID: 32070873
[TBL] [Abstract][Full Text] [Related]
3. PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis.
Liu X; Cai Y; Cheng C; Gu Y; Hu X; Chen K; Wu Y; Wu Z
Cell Death Dis; 2022 Feb; 13(2):178. PubMed ID: 35210406
[TBL] [Abstract][Full Text] [Related]
4. Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors.
Liu X; Cheng C; Cai Y; Gu Y; Wu Y; Chen K; Wu Z
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425993
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis.
Pan L; Sha J; Lin W; Wang Y; Bian T; Guo J
Exp Ther Med; 2021 Sep; 22(3):969. PubMed ID: 34335911
[TBL] [Abstract][Full Text] [Related]
6. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
[TBL] [Abstract][Full Text] [Related]
7. Combined blockade of AKT/mTOR pathway inhibits growth of human hemangioma via downregulation of proliferating cell nuclear antigen.
Ou JM; Qui MK; Dai YX; Dong Q; Shen J; Dong P; Wang XF; Liu YB; Fei ZW
Int J Immunopathol Pharmacol; 2012; 25(4):945-53. PubMed ID: 23298485
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway.
Peng B; Ortega J; Gu L; Chang Z; Li GM
J Biol Chem; 2019 Apr; 294(17):7037-7045. PubMed ID: 30858175
[TBL] [Abstract][Full Text] [Related]
9. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
11. MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.
Long ZW; Wu JH; Cai-Hong ; Wang YN; Zhou Y
Mol Cells; 2018 Jun; 41(6):532-544. PubMed ID: 29902839
[TBL] [Abstract][Full Text] [Related]
12. Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer.
Zhang J; Niu Y; Huang C
Recent Pat Anticancer Drug Discov; 2017; 12(3):247-259. PubMed ID: 28440206
[TBL] [Abstract][Full Text] [Related]
13. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
15. New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract.
Coulombe G; Rivard N
Cell Mol Gastroenterol Hepatol; 2016 Jan; 2(1):11-21. PubMed ID: 28174704
[TBL] [Abstract][Full Text] [Related]
16. Systems biology and OMIC data integration to understand gastrointestinal cancers.
Bispo IMC; Granger HP; Almeida PP; Nishiyama PB; de Freitas LM
World J Clin Oncol; 2022 Oct; 13(10):762-778. PubMed ID: 36337313
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
18. Coactivation of the PI3K/Akt and ERK signaling pathways in PCB153-induced NF-κB activation and caspase inhibition.
Liu C; Yang J; Fu W; Qi S; Wang C; Quan C; Yang K
Toxicol Appl Pharmacol; 2014 Jun; 277(3):270-8. PubMed ID: 24726520
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.
Huang GL; Luo Q; Rui G; Zhang W; Zhang QY; Chen QX; Shen DY
Mol Cell Biol; 2013 Sep; 33(17):3416-25. PubMed ID: 23798555
[TBL] [Abstract][Full Text] [Related]
20. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]